Document is current
Any future updates will be listed below
-
Authors
Calheiros, Juliana
Silva, Rita
Barbosa, Filipa
Morais, João
Moura, Sara Reis
Almeida, Sofia
Fiorini, Elena
Mulhovo, Silva
Aguiar, Tatiana Q.
Wang, Tao
Ricardo, Sara
Almeida, Maria Inês
Domingues, Lucília
Melo, Sonia A.
Corbo, Vincenzo
Ferreira, Maria-José U.
Saraiva, Lucília
-
Funding
Funding for this research was provided by:
FCT/MCTES, Fundação para a Ciência e Tecnologia and Ministério da Ciência, Tecnologia e Ensino Superior (2020.04613.BD, 2022.05718.PTDC, 0.54499/LA/P/0008/2020, 10.54499/UIDP/50006/2020, 10.54499/UIDB/50006/2020, 2020.06020.BD, 2022.05718.PTDC, 0.54499/LA/P/0008/2020, 10.54499/UIDP/50006/2020, 10.54499/UIDB/50006/2020, 2022.05718.PTDC, 0.54499/LA/P/0008/2020, 10.54499/UIDP/50006/2020, 10.54499/UIDB/50006/2020, 2022.05718.PTDC, 0.54499/LA/P/0008/2020, 10.54499/UIDP/50006/2020, 10.54499/UIDB/50006/2020)
Associazione Italiana Ricerca sul Cancro (AIRC; IG No 288801, AIRC; IG No 288801)
National Cancer Institute (NHI; HHSN26100008)
- License Information
-
More Information
Article History
Received: 27 December 2024
Accepted: 8 April 2025
First Online: 24 April 2025
Declarations
:
: This study was approved by the Ethics Committee of the Integrated University Hospital Trust (Comitato Etico Azienda Ospedaliera Universitaria Integrata), University of Verona, Italy (approval number 1885) for studies with patient-derived organoids. For animal studies, all procedures were reviewed and approved by the i3S Animal Welfare and Ethics Body, and the animal protocol was approved by DGAV “Direção Geral de Alimentação e Veterinária”.
: Not applicable.
: An international patent protecting the compound disclosed in this manuscript has been filed by the following authors: Juliana Calheiros, Silva Mulhovo, Maria José U. Ferreira, and Lucília Saraiva. Lucília Saraiva and Maria José U. Ferreira are co-founders of BBIT-Therapeutics, Lda.
